US HIV Market and Competitive Landscape Highlights - 2016

  • ID: 3679150
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US HIV Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into HIV pipeline products, HIV epidemiology, HIV market valuations and forecast, HIV products sales and competitive landscape in the US.

The research is classified into nine sections – HIV overview including etiology, pathophysiology, and diagnosis, HIV treatment options, HIV pipeline products, HIV market analysis comprising of HIV epidemiology, key products marketed for HIV, market valuations and forecast, products sales and market shares.

Research Scope:
- HIV Pipeline: Find out the products in clinical trials for the treatment of HIV by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- HIV Epidemiology: Find out the number of patients diagnosed (prevalence) with HIV in the US
- HIV Products: Identify key products marketed and prescribed for HIV in the US, including trade name, molecule name, and company
- HIV Product Sales: Find out the sales revenues of HIV products, both branded and generics, in the US
- HIV Market Valuations: Find out the market size for HIV products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- HIV Products Market Share: Find out the market shares for key HIV products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national HIV market analysis and sales trends
- Track competitor drugs sales and market share in the US HIV market
- Track competitive developments in HIV market and present key issues and learnings
- Synthesize insights for HIV market and products to drive business performance
- Answer key business questions about the HIV market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for HIV products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) HIV Treatments
3) HIV Pipeline
4) US HIV Epidemiology
5) Marketed Drugs for HIV in US
6) US HIV Market Size
7) US HIV Products Sales
8) US HIV Market Competitive Landscape
9) US HIV Market Forecast
10) Methodology
11) Contact us

1. HIV Epidemiology, US, 2010 - 2020
2. HIV Market Size ($), US, 2010 – 2015
3. HIV Products Market Share (%), US, 2015
4. HIV Market Forecast ($), US, 2015 – 2020

1. HIV Phase 3 Clinical Trials, 2016
2. HIV Phase 2 Clinical Trials, 2016
3. HIV Phase 1 Clinical Trials, 2016
4. HIV Epidemiology, US, 2010 - 2020
5. Marketed Drugs for HIV, US, 2016
6. HIV Market Size ($), US, 2010 – 2015
7. HIV Product Sales ($), US, 2010 – 2015
8. HIV Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll